Who Owns Bionano Genomics Stock?
NASDAQ: BNGOIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 12.95%
- Held by insiders
- 2.76%
- Institutional holders
- 41
- Institutions 12.9%
- Insiders 2.8%
- Public and other 84.3%
Who owns Bionano Genomics stock?
Institutional investors own about 12.9% of Bionano Genomics's shares, spread across 41 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 2.76% of BNGO.
The largest institutional holders are GSA Capital Partners LLP (1.28%), Carret Asset Management, LLC (1.06%) and Geode Capital Management, LLC (0.76%). Together, the top 10 institutions control 5.6% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their BNGO positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of BNGO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| GSA Capital Partners LLP | 150.28K | 1.28% | -57.5% |
| Carret Asset Management, LLC | 125.00K | 1.06% | +78.6% |
| Geode Capital Management, LLC | 89.99K | 0.76% | -46.3% |
| Vanguard Capital Management LLC | 82.39K | 0.70% | +21.0% |
| Vanguard Fiduciary Trust Co | 51.58K | 0.44% | 0.0% |
| Renaissance Technologies, LLC | 51.10K | 0.43% | +4.9% |
| Jane Street Group, LLC | 35.73K | 0.30% | +100.0% |
| Prudential Financial, Inc. | 31.60K | 0.27% | +12.9% |
| Northern Trust Corporation | 24.56K | 0.21% | +19.7% |
| Xtx Topco Ltd | 16.30K | 0.14% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of BNGO
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 82.39K | 0.70% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 56.44K | 0.48% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 11.47K | 0.10% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 2.77K | 0.02% |
| TR PRICE-Price (T.Rowe) U.S. Equities Trust | 1.49K | 0.01% |
Frequently asked questions
Who is the largest shareholder of Bionano Genomics?
GSA Capital Partners LLP is the largest institutional shareholder of BNGO, owning 1.28% of shares outstanding (150.28K shares) as of its latest 13F filing.
What percentage of Bionano Genomics is owned by institutions?
Institutions own about 12.9% of BNGO shares and 13.3% of the public float.
How much of Bionano Genomics do insiders own?
Insiders, such as officers and directors, own about 2.76% of BNGO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.